연구동향 분석

Combined Let-7a and H19 Signature: A Prognostic Index of Progression-Free Survival in Primary Breast Cancer Patients

Qiannan Guo Runyao Wen Bin Shao Yudong Li Xin Jin Heran Deng Jiannan Wu Fengxi Su Fengyan Yu 2018년

논문상세정보
    • 저자 Qiannan Guo Runyao Wen Bin Shao Yudong Li Xin Jin Heran Deng Jiannan Wu Fengxi Su Fengyan Yu
    • 제어번호 106054570
    • 학술지명 Journal of breast cancer
    • 권호사항 Vol. 21 No. 2 [ 2018 ]
    • 발행처 한국유방암학회
    • 자료유형 학술저널
    • 수록면 142-149 ( 8쪽)
    • 언어 English
    • 출판년도 2018
    • 등재정보 KCI등재
    • 소장기관 강원대학교 춘천캠퍼스 도서관 의학분관 경북대학교 도서관 의학분관 고려대학교 의학도서관 부산대학교 중앙도서관 영남대학교 의료원 의학도서관 충남대학교 의학도서관
    • 판매처
    유사주제 논문( 0)
인용/피인용

' Combined Let-7a and H19 Signature: A Prognostic Index of Progression-Free Survival in Primary Breast Cancer Patients' 의 참고문헌

  • c-Myc-regulated long non-coding RNA H19 indicates a poor prognosis and affects cell proliferation in non-small-cell lung cancer
    Zhang E [2016]
  • X-tile: a new bio-informatics tool for biomarker assessment and outcome-based cut-point optimization
    Camp RL [2004]
  • The imprinted H19 lncRNA antagonizes let-7 microRNAs
    Kallen AN [2013]
  • The H19 locus: role of an imprinted non-coding RNA in growth and development
    Gabory, A. [2010]
  • Reduced let-7a is associated with chemoresistance in primary breast cancer
    Wu J [2015]
  • Recommendations from an international expert panel on the use of neoadjuvant (primary) systemic treatment of operable breast cancer: new perspectives 2006
    Kaufmann M [2007]
  • Preoperative chemotherapy: updates of National Surgical Adjuvant Breast and Bowel Project Protocols B-18 and B-27
    Rastogi P [2008]
  • Neoadjuvant versus adjuvant systemic treatment in breast cancer: a meta-analysis
    Mauri D [2005]
  • MicroRNA gene expression deregulation in human breast cancer
    Iorio MV [2005]
  • MicroRNA expression and clinical outcomes in patients treated with adjuvant chemotherapy after complete resection of non-small cell lung carcinoma
    Voortman J [2010]
  • Long noncoding RNAs and microRNAs in cardiovascular pathophysiology
    Thum T [2015]
  • LncRNA H19 confers chemoresistance in <TEX>$ER{\alpha}$</TEX>-positive breast cancer through epigenetic silencing of the pro-apoptotic gene BIK
    Si X [2016]
  • Identification of the long noncoding RNA H19 in plasma as a novel biomarker for diagnosis of gastric cancer
    Zhou X [2015]
  • H19/let-7/LIN28 reciprocal negative regulatory circuit promotes breast cancer stem cell maintenance
    Peng F [2017]
  • H19 non coding RNA-derived miR-675 enhances tumorigenesis and metastasis of breast cancer cells by downregulating c-Cbl and Cbl-b
    Vennin C [2015]
  • Expression of circulating microRNA-20a and let-7a in esophageal squamous cell carcinoma
    He FC [2015]
  • Breast and cervical cancer in 187 countries between 1980 and 2010: a systematic analysis
  • Association of genetic variants in lncRNA H19 with risk of colorectal cancer in a Chinese population
    Li, S. [2016]
  • A nucleolar protein, H19 opposite tumor suppressor (HOTS), is a tumor growth inhibitor encoded by a human imprinted H19 antisense transcript
    Onyango P [2011]